1. Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis. Issue 1 (6th January 2022) Authors: Mulder, Christiaan; Rupert, Stephan; Setiawan, Ery; Mambetova, Elmira; Edo, Patience; Sugiharto, Jhon; Useni, Sani; Malhotra, Shelly; Cook-Scalise, Sarah; Pambudi, Imran; Kadyrov, Abdullaat; Lawanson, Adebola; van den Hof, Susan; Gebhard, Agnes; Juneja, Sandeep; Sohn, Hojoon Journal: BMJ global health Issue: Volume 7:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making. (11th December 2020) Authors: Botwright, Siobhan; Kahn, Anna-Lea; Hutubessy, Raymond; Lydon, Patrick; Biey, Joseph; Karim Sidibe, Abdoul; Diarra, Ibrahima; Nadjib, Mardiati; Suwantika, Auliya A.; Setiawan, Ery; Archer, Rachel; Kristensen, Debra; Menozzi-Arnaud, Marion; Mpia Bwaka, Ado; Mwenda, Jason M.; Giersing, Birgitte K. Journal: Vaccine Issue: Volume 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗